Provides digital marketing and audience-targeting services for life sciences brands, reaching healthcare providers through electronic health records and patients through consumer media.
10-K for FY2025, filed Mar 12, 2026After acquiring Healthy Offers, Inc. (d/b/a “Medicx” or “Medicx Health”) in 2023, we expanded our capabilities to include…View ↗
Customers are able to execute traditional marketing campaigns utilizing our proprietary digital point-of-care network, as well as dynamic…View ↗
Our primary media offering is banner messaging delivered to HCPs. Banner messages include brand messaging, therapeutic support messaging…View ↗
Life sciences clients buy message-delivery campaigns and data subscriptions. Campaign charges can be per message or redemption, a flat fee over a period, or tied to program completion; campaign revenue comes as messages are distributed.
10-K for FY2025, filed Mar 12, 2026
10-K for FY2025, filed Mar 12, 2026
FY2025 revenue by product or service ↗$109.4M
10-K for FY2025, filed Mar 12, 2026
$109.4M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Revenue recognized over time
|
100% |
Revenue recognized over time, FY2025
$109.2M Sources
|
|
|
Revenue recognized at a point in time
Sold outright
|
0.2% |
Revenue recognized at a point in time, FY2025
$215K Sources
|
Sold outright |
Life sciences manufacturers and brands, along with their agencies, use OptimizeRx's platform for campaigns aimed at healthcare providers and consumer audiences.
10-K for FY2025, filed Mar 12, 2026Our go-to-market strategy for the business aligns sales and marketing efforts while keeping customer engagement at the core. Engaging…View ↗
Our proprietary technology platform enables us to curate privacy safe DTC audiences, dynamic HCP and DTC audiences, and effectively manage…View ↗
Customers are able to execute traditional marketing campaigns utilizing our proprietary digital point-of-care network, as well as dynamic…View ↗
Yes. It kept 5 cents of every revenue dollar as net income in FY2025 and turned 17 cents into free cash flow.
10-K for FY2025, filed Mar 12, 2026
$11.7MView ↗
10-K for FY2025, filed Mar 12, 2026
$5.1MView ↗
10-K for FY2025, filed Mar 12, 2026
$18.7MView ↗
10-Q for Q2 FY2026, filed Aug 13, 2026
−$703KView ↗
8-K, filed Aug 12, 2026
The Company is reiterating its fiscal year 2026 guidance, and expects revenue of $95 million to $100 million and adjusted EBITDA of $21…View ↗
8-K, filed May 12, 2026
-2026 revenue guidance updated to $95-$100 million; adjusted EBITDA guidance unchanged at $21-$25 millionView ↗
8-K, filed Mar 30, 2026
On March 24, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of OptimizeRx Corporation (the “Company”) approved…View ↗
Growing. Revenue grew 79% in 4 years, from $61.3M in FY2021 to $109.4M in FY2025, about 16% a year.
Geotargeted consumer marketing
The latest report describes consumer marketing to audiences in geographies where eligible patients live, activated through multiple media channels; the older report describes mobile messages for patient adherence and care coordination.
10-K for FY2022, filed Mar 10, 2023 10-K for FY2025, filed Mar 12, 2026Patient Engagement – Our technology solution provides digital messaging services through our cloud-based Mobile Health Messenger (“MHM”)…View ↗
Competes with ConnectiveRx
10-K for FY2022, filed Mar 10, 2023Our platforms compete broadly in the highly competitive pharmaceutical and life sciences digital marketing industry that is dominated by…View ↗
Loading...